We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$2.71B
AUM Growth
+$676M
Cap. Flow
+$366M
Cap. Flow %
13.5%
Top 10 Hldgs %
53.14%
Holding
77
New
23
Increased
4
Reduced
17
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 12.24%
2 Communication Services 8.42%
3 Financials 7.32%
4 Technology 6.87%
5 Industrials 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$579M 21.36%
+2,839,000
New +$583M
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$163M 6.02%
800,000
-900,000
-53% -$185M
SIG icon
3
CALL
Signet Jewelers
SIG
$3.84B
$124M 4.57%
+1,000,000
New +$135M
TLT icon
4
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$95.5M 3.52%
791,900
-155,400
-16% -$18.9M
TWC
5
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$90.9M 3.35%
+489,719
New +$90.8M
LTRPA
6
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$87.9M 3.24%
2,896,032
+51,000
+2% +$1.5M
ISBC
7
DELISTED
Investors Bancorp, Inc.
ISBC
$87M 3.21%
6,989,604
-2,000,000
-22% -$25.2M
HUM icon
8
Humana
HUM
$43.9B
$79.4M 2.93%
+445,000
New +$78.1M
FXE icon
9
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$344M
$71M 2.62%
667,700
-621,100
-48% -$66.7M
PFE icon
10
Pfizer
PFE
$143B
$62.5M 2.31%
2,040,017
-304,079
-13% -$9.57M
BRCM
11
DELISTED
BROADCOM CORP CL-A
BRCM
$61.5M 2.27%
+1,064,000
New +$57.3M
CMCSA icon
12
Comcast
CMCSA
$87.3B
$57.8M 2.14%
2,050,000
-1,400,000
-41% -$42.2M
ARMK icon
13
Aramark
ARMK
$15B
$57.2M 2.11%
2,454,640
-554,000
-18% -$12.7M
TFSL icon
14
TFS Financial
TFSL
$5.11B
$56.5M 2.09%
3,000,000
-745,000
-20% -$13.7M
IWM icon
15
CALL
iShares Russell 2000 ETF
IWM
$79.1B
$56.3M 2.08%
500,000
AGN
16
DELISTED
Allergan plc
AGN
$56M 2.07%
179,210
+70,210
+64% +$20.9M
SYF icon
17
Synchrony
SYF
$24.4B
$53.2M 1.96%
+1,748,000
New +$54.8M
RAD
18
DELISTED
Rite Aid Corporation
RAD
$50.8M 1.88%
+324,250
New +$48M
ENDP
19
DELISTED
Endo International plc
ENDP
$49M 1.81%
+800,000
New +$48.6M
ABBV icon
20
AbbVie
ABBV
$465B
$47.4M 1.75%
800,000
-100,000
-11% -$5.76M
SRG
21
Seritage Growth Properties
SRG
$138M
$43.1M 1.59%
1,072,500
+572,500
+115% +$22.2M
EMC
22
DELISTED
EMC CORPORATION
EMC
$41.1M 1.52%
+1,600,000
New +$41.5M
AMAT icon
23
Applied Materials
AMAT
$347B
$38.8M 1.43%
2,079,200
-1,970,800
-49% -$34.2M
FWONK icon
24
Liberty Media Series C
FWONK
$25.5B
$38.3M 1.42%
1,422,428
INVA icon
25
Innoviva
INVA
$1.6B
$37.3M 1.38%
3,538,858
+796,556
+29% +$7.33M

Similar funds

Empyrean Capital Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Empyrean Capital Partners held 77 positions worth $2.71B, up 33% from $2.03B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Empyrean Capital Partners deployed $366M of net new capital in Q4 2015, opening 23 new positions and adding to 4 existing holdings. Its largest new stake was TIME WARNER CABLE INC NEW COM STK: 489,719 shares worth $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.3% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Comcast, an estimated $42.2M trimmed.

  • Empyrean Capital Partners's largest Q4 2015 buy was TIME WARNER CABLE INC NEW COM STK: 489,719 shares worth $90.9M.
  • Empyrean Capital Partners added most to Seritage Growth Properties in Q4 2015, an estimated $22.2M increase.
  • Empyrean Capital Partners's biggest Q4 2015 reduction was Comcast, cutting an estimated $42.2M.
  • Empyrean Capital Partners fully exited Molson Coors Class B in Q4 2015, selling an estimated $32.1M.
  • Empyrean Capital Partners's ten largest holdings make up 53% of its $2.71B portfolio in Q4 2015.
  • Empyrean Capital Partners opened 23 new positions and closed 8 in Q4 2015.
  • Empyrean Capital Partners's portfolio value rose 33% quarter-over-quarter to $2.71B.

Based on Empyrean Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.